Try it
Pharmacology · Antimicrobials: respiratory fluoroquinolones
Sample itemWhich pair of fluoroquinolones have enhanced activity against Streptococcus pneumoniae and atypical organisms and are called respiratory quinolones?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Levofloxacin and moxifloxacin
Levofloxacin and moxifloxacin have improved pneumococcal and atypical cover compared with ciprofloxacin, which is weak against pneumococci. Because they are active against Mycobacterium tuberculosis, their empirical use in pneumonia can delay tuberculosis diagnosis.
Option by option
A. Nalidixic acid and cinoxacin
These are older quinolones without respiratory activity.
B. Levofloxacin and moxifloxacin (correct)
Correct. These are the respiratory quinolones.
C. Ciprofloxacin and norfloxacin
Ciprofloxacin is weak against pneumococcus.
D. Norfloxacin and ofloxacin
Norfloxacin has limited tissue levels.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?